Antiphospholipid syndrome in ischemic stroke patients

被引:0
|
作者
Okuma, H. [1 ]
Kodera, Y. [1 ]
Yasuda, T. [1 ]
Tokuoka, K. [1 ]
Kitagawa, Y. [1 ]
机构
[1] Tokai Univ, Hachioji Hosp, Tokyo 151, Japan
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
WSC-0405
引用
收藏
页码:282 / 282
页数:1
相关论文
共 50 条
  • [1] THE ANTIPHOSPHOLIPID SYNDROME - PREVALENCE AMONG PATIENTS WITH STROKE AND TRANSIENT ISCHEMIC ATTACKS
    TRIMBLE, M
    BELL, DA
    BRIEN, W
    HACHINSKI, V
    OKEEFE, B
    MCLAY, C
    BLACK, J
    AMERICAN JOURNAL OF MEDICINE, 1990, 88 (06): : 593 - 597
  • [2] Risk of hemorrhagic transformation after ischemic stroke in patients with antiphospholipid antibody syndrome
    Mehta, Tapan
    Hussain, Mohammed
    Sheth, Khushboo
    Ding, Yuchuan
    McCullough, Louise D.
    NEUROLOGICAL RESEARCH, 2017, 39 (06) : 477 - 483
  • [3] Mutations of genes associated with thromboses in ischemic stroke in patients with primary antiphospholipid syndrome
    Kalashnikova, LA
    Dobrynina, LA
    Patrusheva, NL
    Kovalenko, TF
    Patrushev, LI
    Aleksandrova, EN
    Berkovsky, AL
    Sergeeva, EV
    Nasonov, EL
    TERAPEVTICHESKII ARKHIV, 2005, 77 (10): : 49 - 53
  • [4] Thrombolysis for acute ischemic stroke in the primary antiphospholipid syndrome
    Julkunen, H
    Hedman, C
    Kauppi, M
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (01) : 181 - 183
  • [5] ISCHEMIC STROKE IN PRIMARY ANTIPHOSPHOLIPID SYNDROME: A CASECONTROL STUDY
    Matus, R.
    Merayo-Chalico, J.
    Aguirre-Aguilar, E.
    Barrera-Vargas, A.
    Cano-Nigenda, V.
    Campos-Guzman, J.
    Farington-Tercero, E.
    Govea-Pelaez, S.
    Mendez-Gallardo, J. J.
    Valdez-Lopez, M.
    Barboza, M. A.
    Arauz, A.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 510 - 510
  • [6] The role of antiphospholipid antibodies in patients with ischemic stroke
    Grunauer, M.
    Raicevic, R.
    Stojkovic, M.
    Pasovski, V.
    Selakovic, V.
    CEREBROVASCULAR DISEASES, 2018, 45 : 482 - 482
  • [7] Stroke and antiphospholipid syndrome—antiphospholipid antibodies are a risk factor for an ischemic cerebrovascular event
    Nataša Gašperšič
    Marjan Zaletel
    Jan Kobal
    Polona Žigon
    Saša Čučnik
    Snežna Sodin Šemrl
    Matija Tomšič
    Aleš Ambrožič
    Clinical Rheumatology, 2019, 38 : 379 - 384
  • [8] HOW WE SHOULD TREAT THE PATIENTS WITH CRYPTOGENIC ISCHEMIC STROKE OR TRANSIENT ISCHEMIC ATTACKS AND ANTIPHOSPHOLIPID SYNDROME?
    Bermejo, N.
    Martin Aguilera, C.
    Banas, H.
    Arcos, M. J.
    Ibanez, F.
    Salgado, R.
    Casas, I.
    Carnicero, F.
    Bergua, J.
    HAEMATOLOGICA, 2014, 99 : 782 - 783
  • [9] THE GLOBAL ANTIPHOSPHOLIPID SYNDROME SCORE (GAPSS) DIFFERENTIATES BETWEEN TRANSIENT ISCHEMIC ATTACK AND STROKE IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
    Sciascia, S.
    Sanna, G.
    Murru, V.
    Roccatello, D.
    Khamashta, M.
    Bertolaccini, M. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 581 - 581
  • [10] A novel aGAPSS-based nomogram for the prediction of ischemic stroke in patients with antiphospholipid syndrome
    Song, Xiaodong
    Fan, Yangyi
    Jia, Yuan
    Li, Gongming
    Liu, Meige
    Xu, Yicheng
    Zhang, Jun
    Li, Chun
    FRONTIERS IN IMMUNOLOGY, 2022, 13